Literature DB >> 10704691

Microsatellite instability in ovarian and other pelvic carcinomas.

H J Allen1, R A DiCioccio, P Hohmann, M S Piver, H Tworek.   

Abstract

Twenty-six cases of ovarian carcinoma and six cases of other pelvic neoplasms were analyzed for microsatellite instability (MSI) using frozen specimens, fluorescence technology, and four selected markers (D2S123 on chromosome 2, D18S58 on chromosome 18, BAT26 on chromosome 2, and BAT40 on chromosome 1). This procedure also allowed the detection of loss of heterogeneity (LOH) at the four selected loci. One of the cases of ovarian carcinoma exhibited MSI and this was evident at three loci. Of 44 informative loci, 7 exhibited LOH representing 3 cases of ovarian carcinoma, 3 of 4 cases of primary peritoneal carcinoma, and one case of unknown primary. These data support other findings that MSI is not a frequent occurrence in ovarian cancer; however, LOH is a more frequent event and may be a target for the development of diagnostic/prognostic procedures for ovarian and primary peritoneal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704691     DOI: 10.1016/s0165-4608(99)00167-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

Review 1.  Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America.

Authors:  Megan A Murphy; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-04-04       Impact factor: 7.396

2.  Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer.

Authors:  A J Alvi; J S Rader; M Broggini; F Latif; E R Maher
Journal:  Mol Pathol       Date:  2001-08

Review 3.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 4.  Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.

Authors:  Tuya Pal; Jenny Permuth-Wey; Ambuj Kumar; Thomas A Sellers
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 5.  A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer.

Authors:  Tuya Pal; Jenny Permuth-Wey; Thomas A Sellers
Journal:  Cancer       Date:  2008-08-15       Impact factor: 6.860

6.  Mismatch repair and treatment resistance in ovarian cancer.

Authors:  Jozien Helleman; Iris L van Staveren; Winand N M Dinjens; Patricia F van Kuijk; Kirsten Ritstier; Patricia C Ewing; Maria E L van der Burg; Gerrit Stoter; Els M J J Berns
Journal:  BMC Cancer       Date:  2006-07-31       Impact factor: 4.430

7.  A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer.

Authors:  Y Watanabe; M Koi; H Hemmi; H Hoshai; K Noda
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

8.  Population analysis of microsatellite genotypes reveals a signature associated with ovarian cancer.

Authors:  Natalie C Fonville; Zalman Vaksman; Lauren J McIver; Harold R Garner
Journal:  Oncotarget       Date:  2015-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.